Characterization of microRNAs expression profiling in one group of Chinese urothelial cell carcinoma identified by Solexa sequencing

Urologic Oncology: Seminars and Original Investigations

Volumn 31, Issue 2, 2013, Pages 219-227

  Chen, Yu Hua ^a   Wang, Si Qi ^a   Wu, Xiu Ling ^a   Shen, Mo ^a   Chen, Zhan Guo ^a   Chen, Xiao Gang ^a   Liu, Yong Xia ^a   Zhu, Xiao Li ^a   Guo, Fei ^a   Duan, Xiu Zhi ^a   Han, Xiu Cui ^a   Tao, Zhi Hua ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Bladder cancer; Laser capture microdissection; MicroRNAs; Solexa sequencing

Indexed keywords

MICRORNA;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER EPITHELIUM; CARCINOGENESIS; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM TUMOR; FEMALE; HUMAN; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; MALE; PRIORITY JOURNAL; RNA ANALYSIS; TRANSITIONAL CELL CARCINOMA; TUMOR CELL; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, TRANSITIONAL CELL; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; LASER CAPTURE MICRODISSECTION; MALE; MICRORNAS; MIDDLE AGED; SEQUENCE ANALYSIS, RNA; TRANSCRIPTOME; URINARY BLADDER NEOPLASMS;

EID: 84875256362     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2010.11.007     Document Type: Article

References (39)

1. Zhang S.W., Ma J.H., Li M., et al. Incidence trends of bladder cancer in cities and counties in China. Chin J Urol 2009, 30:673-676.
2. Parkin D.M. The global burden of urinary bladder cancer. Scand J Urol Nephrol 2008, 218(Suppl):12-20.
3. Zhang B.H., Wang Q.L., Pan X.P. MicroRNAs and their regulatory roles in animals and plants. J Cell Physiol 2007, 210:279-289.
4. Wu L., Fan J., Belasco J.G. MicroRNAs direct rapid deadenylation of mRNA. Proc Natl Acad Sci U S A 2006, 103:4034-4039.
5. Zhang B., Pan X., Cobb G.P., et al. MicroRNAs as oncogenes and tumor suppressors. Dev Biol 2007, 302:1-12.
6. Lynam-Lennon N., Maher S.G., Reynolds J.V. The roles of microRNA in cancer and apoptosis. Biol Rev Camb Philos Soc 2009, 84:55-71.
7. Papagiannakopoulos T., Kosik K.S. MicroRNAs: Regulators of oncogenesis and stemness. BMC Med 2008, 6:15.
8. Wang V., Wu W. MicroRNA-based therapeutics for cancer. BioDrugs 2009, 23:15-23.
9. Hummel R., Hussey D.J., Haier J. MicroRNAs: Predictors and modifiers of chemo- and radiotherapy in different tumor types. Eur J Cancer 2010, 46:298-311.
10. Calin G.A., Dumitru C.D., Shimizu M., et al. Frequent deletions and down-regulation of microRNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002, 99:15524-15529.
11. Patnaik S.K., Kannisto E., Knudsen S., et al. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small-cell lung cancer after surgical resection. Cancer Res 2010, 70:36-45.
12. Ji J., Shi J., Budhu A., et al. MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 2009, 361:1437-1447.
13. Tie J., Pan Y., Zhao L., et al. MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet 2010, 6:e1000879.
14. Arndt G.M., Dossey L., Cullen L.M., et al. Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer 2009, 9:374.
15. Fassan M., Baffa R., Palazzo J.P., et al. MicroRNA expression profiling of male breast cancer. Breast Cancer Res 2009, 11:R58.
16. DeVere White R.W., Vinall R.L., Tepper C.G., et al. MicroRNAs and their potential for translation in prostate cancer. Urol Oncol 2009, 27:307-311.
17. Gottardo F., Liu C.G., Ferracin M., et al. MicroRNA profiling in kidney and bladder cancers. Urol Oncol 2007, 25:387-392.
18. Lin T.X., Dong W., Huang J., et al. MicroRNA-143 as a tumor suppressor for bladder cancer. J Urol 2009, 181:1372-1380.
19. Dyrskjøt L., Ostenfeld M.S., Bramsen J.B., et al. Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res 2009, 69:4851-4860.
20. Neely L.A., Rieger-Christ K.M., Neto B.S., et al. A microRNA expression ratio defining the invasive phenotype in bladder tumors. Urol Oncol 2010, 28:39-48.
21. Sobin L.H., Wittekind Ch. TNM Classification of Malignant Tumours 2002, International Union against Cancer, Wiley-Liss, New York (NY). 6th ed.
22. Espina V., Wulfkuhle J.D., Calvert V.S., et al. Laser-capture microdissection. Nat Protoc 2006, 1:586-603.
23. Liu S.P., Li D., Li Q.B., et al. MicroRNAs of Bombyx mori identified by Solexa sequencing. BMC Genomics 2010, 11:148.
24. Li R.Q., Li Y.R., Kristiansen K., et al. SOAP: Short oligonucleotide alignment program. Bioinformatics 2008, 24:713-714.
25. Mireap Accessed June 8, 2010. http://sourceforge.net/projects/mireap/.
26. Audic S., Claverie J.M. The significance of digital gene expression profiles. Genome Res 1997, 7:986-995.
27. Sultan M., Schulz M.H., Richard H., et al. A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome. Science 2008, 321:956-960.
28. Benjamini Y., Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R. Stat Soc Ser B Methodol 1995, 57:289-300.
29. Hafner M., Landgraf P., Ludwig J., et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 2008, 44:3-12.
30. Berezikov E., Cuppen E., Plasterk R.H. Approaches to microRNA discovery. Nat Genet 2006, 38(Suppl):S2-S7.
31. Zhang J.G., Xu Y.Y., Huan Q., et al. Deep sequencing of Brachypodium small RNAs at the global genome level identifies microRNAs involved in cold stress response. BMC Genomics 2009, 10:449.
32. Chatterjee S., Grosshans H. Active turnover modulates mature microRNA activity in Caenorhabditis elegans. Nature 2009, 461:546-549.
33. Wang G., Zhang H.H., He H.D., et al. Up-regulation of microRNA in bladder tumor tissue is not common. Int Urol Nephrol 2010, 42:95-102.
34. Ichimi T., Enokida H., Okuno Y., et al. Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int J Cancer 2009, 125:345-352.
35. Chiyomaru T., Enokida H., Tatarano S., et al. MiR-145 and miR-133a function as tumor suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer 2010, 102:883-891.
36. Ostenfeld M.S., Bramsen J.B., Lamy P., et al. MiR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors. Oncogene 2010, 29:1073-1084.
37. Catto J.W., Miah S., Owen H.C., et al. Distinct microRNA alterations characterize high- and low-grade bladder cancer. Cancer Res 2009, 69:8472-8481.
38. Hanke M., Hoefig K., Merz H., et al. A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol Oncol 2010, 28:655-661.
39. He L., Hannon G.J. MicroRNAs: Small RNAs with a big role in gene regulation. Nat Rev Genet 2004, 5:522-531.